𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of selenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells

✍ Scribed by Adriana Stoica; Elizabeth Pentecost; Mary Beth Martin

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
160 KB
Volume
79
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogenic and anti-estrogenic regulatio
Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: Comparison of immunocytochemical data with biochemical measurements
✍ Hye-Sook Seo; Denis Larsimont; Gilbert Querton; Abdelhamid El Khissiin; Ioanna L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 153 KB 👁 2 views

Data from immunocytochemical assessment of estrogen receptor (ER) regulation in MCF-7 cells under estrogenic and anti-estrogenic stimulation were compared with those obtained by enzyme immunoassay (Abbott ER-EIA). Similar trends were observed, although ER level variations were less marked when asses

Regulation of estrogen receptor-α gene e
Regulation of estrogen receptor-α gene expression by 1,25-dihydroxyvitamin D in MCF-7 cells
✍ Adriana Stoica; Miguel Saceda; Amina Fakhro; Harrison B. Solomon; Bradley D. Fen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

This report describes an investigation of the role of 1,25-dihydroxyvitamin D (VD 3 ) in the regulation of estrogen receptor-␣ (ER) in the ER-positive breast cancer cell line, MCF-7. Treatment of cells with 10 nM VD 3 resulted in a 50% decline in the concentration of ER protein at 24 h. Scatchard an

Electromagnetic fields alter the express
Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells
✍ Rainer Girgert; Carsten Gründker; Günter Emons; Volker Hanf 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract Breast cancer is the most common malignancy of women in Western societies. The increasing exposure to electromagnetic fields has been suspected to contribute to the rising incidence of breast cancer in industrialized countries. The majority of breast tumors is treated with the partial a

Expression of transforming growth factor
Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells
✍ Yong Ko; Sunandita S. Banerji; Yu Liu; Wenhui Li; Jiurong Liang; Herbert D. Soul 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 1 views

To analyze transforming growth factor-b (TGF-b) response during MCF-7 cell progression, early passage (MCF-7E, õ200 passage) and late passage (MCF-7L, ú 500 passage) cells were compared. MCF-7E cells showed an IC 50 of Ç10 ng/ ml of TGF-b1, whereas MCF-7L cells were insensitive. MCF-7E cells contain

Time-related effects of estrogen withdra
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts
✍ Simone Detre; Janine Salter; Diana M. Barnes; Sharon Riddler; Margaret Hills; St 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB

Endocrine treatments for human breast cancer have been based largely upon the removal of estrogenic stimuli. The regression of tumors after estrogen deprivation has generally been characterized as being due to reduced proliferation but more recently has been recognized to also involve increased apop

bcl-2 over-expression enhances NF-κB act
bcl-2 over-expression enhances NF-κB activity and induces mmp-9 transcription in human MCF7ADR breast-cancer cells
✍ Alfredo Ricca; Annamaria Biroccio; Donatella Del Bufalo; Andrew R. Mackay; Angel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 204 KB 👁 1 views

bcl-2 expression is often associated with poor prognosis in several types of tumors; however, the role of this molecule in breast cancer is still controversial. We found earlier that over-expression of bcl-2 in a human breast-cancer cell line (MCF7 ADR ) enhances its tumorigenicity and metastatic po